ClinicalTrials.Veeva

Menu
D

DelRicht Research | Springer Wellness and Restorative Health

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Azetukalner
PF-08653944
Galcanezumab
Clascoterone

Parent organization

This site is a part of DelRicht Research

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

7 of 12 total trials
Locations recently updated

A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)

X-NOVA3 is a Phase 3, multicenter, randomized, double-blind, placebo-controlled study to evaluate the clinical efficacy, safety, and tolerability of...

Enrolling
Major Depressive Disorder
Drug: Azetukalner
Drug: Placebo

This is a double-blind, placebo-controlled study where subjects are participating for approximately 36 to 40 weeks. The study compares how well BFB75...

Enrolling
Hidradenitis Suppurativa (HS)
Other: Placebo for BFB759
Biological: BFB759

The purpose of this study is to evaluate the efficacy and safety of mRNA-1283 and mRNA-1273 (variant formulations) in adults 50 to 64 years of age wi...

Enrolling
SARS-CoV-2
Biological: mRNA-1283
Biological: mRNA-1273

The purpose of this study is to evaluate how well CD388 works in preventing symptomatic laboratory-confirmed influenza infections, as compared to pla...

Active, not recruiting
Influenza
Combination Product: CD388 Injection
Combination Product: Placebo

This study is designed to find out how well the COVID-19 vaccine protects people 50 to 64, who don't have any serious health problems, compared to a...

Enrolling
COVID-19
SARS-COV-2 Infection
Biological: Placebo
Biological: BNT162b2 Vaccine

The purpose of this clinical study is to learn about the safety and effects of the study medicine to help adults with obesity or overweight and type...

Enrolling
Overweight and/or Obesity
Overweight
Drug: PF-08653944
Other: Placebo

X-NOVA-OLE is a multicenter, open-label study to evaluate the long-term safety, tolerability, and efficacy of azetukalner as a monotherapy in adult p...

Invitation-only
Major Depressive Disorder
Drug: Azetukalner

Trial sponsors

C
Moderna logo
X
BioNTech logo
C
K
Lilly logo
Pfizer logo
B

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems